An iron hand over cancer stem cells

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Cancer stem cells (CSCs) drive tumor relapse and chemoresistance.
• Salinomycin shows promise as an anti-CSC agent, but its mechanism is unclear.
• Small molecules can modulate CSC proliferation.

Purpose of the Study:

• To elucidate the mechanism of action of salinomycin and its derivative, ironomycin, against CSCs.
• To investigate the role of iron homeostasis in CSC survival and drug response.

Main Methods:

• Chemical biology approaches using salinomycin and ironomycin.
• Analysis of lysosomal iron levels and iron translocation.
• Assessment of ferritin degradation and reactive oxygen species (ROS) production.
• Cell death pathway analysis, including ferroptosis markers.

Main Results:

• Salinomycin and ironomycin sequester lysosomal iron by blocking translocation.
• This induces iron depletion, ferritin degradation, and ROS production.
• The compounds trigger a cell death pathway similar to ferroptosis.
• Iron homeostasis is critical for CSC survival.

Conclusions:

• Salinomycin and ironomycin exert anti-CSC effects by disrupting lysosomal iron homeostasis.
• Targeting iron metabolism presents a novel therapeutic strategy for CSCs.
• These findings open new avenues for developing anti-cancer stem cell drugs.